Sumitomo Pharma Canada News and Activities

Sumitomo Pharma Canada is owned by Sumitomo Chemical.

Sumitomo Chemical is one of the...

• Forbes Global 2000 (#1476);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Sumitomo Chemical is a company listed under the stock ticker 4005 (JP).

Sumitomo Chemical has a direct presence in 6 countries.

Sumitomo Chemical has 20 subsidiaries including Aetion, Aramis Biosciences and Asahi Chemical.

They are in:

• Biotechnology52%
• Chemicals24%
• Other24%

View the org chart displaying its 3 main executives

Most searched biographies at Sumitomo Pharma Canada

• Lisa Mullett, Managing Director
• Valerie Lowe, Director, Finance
• Sam Miceli, Business Director

Popular executive movements at Sumitomo Pharma Canada

• William Neeson, Director of Scientific Affairs, has left the company  (posted on September 10 2025).

Create your alert
to follow the executive moves at Sumitomo Pharma Canada.

Sumitomo Chemical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Sumitomo Pharma Canada

Social media about Sumitomo Pharma Canada

• Sumitomo Pharma Canada on Wikipedia, Google News & Yahoo Finance
• Sumitomo Pharma Canada on LinkedIn, X (Twitter) & YouTube